Senseonics Holdings (SENS) Capital Expenditures (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.62% |
| Dec 31, 2025 | -200.00% |
| Sep 30, 2025 | 275.79% |
| Jun 30, 2025 | -187.56% |
| Mar 31, 2025 | 124.29% |
| Dec 31, 2024 | -780.30% |
| Sep 30, 2024 | -109.70% |
| Jun 30, 2024 | 562.03% |
| Mar 31, 2024 | 4,614.29% |
| Dec 31, 2023 | -105.69% |
| Sep 30, 2023 | 1,266.67% |
| Jun 30, 2023 | -81.25% |
| Mar 31, 2023 | -15.79% |
| Dec 31, 2022 | 29.55% |
| Sep 30, 2022 | -40.54% |
| Jun 30, 2022 | -45.99% |
| Mar 31, 2022 | 404.44% |
| Dec 31, 2021 | -260.71% |
| Sep 30, 2021 | -22.22% |
| Jun 30, 2021 | 227.27% |
| Sep 30, 2020 | 675.00% |
| Jun 30, 2020 | -158.33% |
| Mar 31, 2020 | 105.22% |
| Dec 31, 2019 | -217.67% |
| Sep 30, 2019 | 451.80% |
| Jun 30, 2019 | -156.63% |
| Mar 31, 2019 | 177.62% |
| Dec 31, 2018 | -199.61% |
| Sep 30, 2018 | 211.04% |
| Jun 30, 2018 | 1,153.85% |
| Mar 31, 2018 | -72.92% |
| Dec 31, 2017 | -52.48% |
| Sep 30, 2017 | -39.88% |
| Jun 30, 2017 | 500.00% |
| Mar 31, 2017 | 3.70% |
| Dec 31, 2016 | -70.00% |
| Sep 30, 2016 | -72.31% |
| Jun 30, 2016 | 778.38% |
| Sep 30, 2015 | 101.64% |